Villers-lès-Nancy, May 26, 2015 - 18h30 (CET)
PRESS RELEASE
Annual Ordinary and Extraordinary General Meeting
Preliminary Notice
PHARMAGEST INTERACTIVE hereby provides notice to shareholders of the annual ordinary and extraordinary general meeting to be held on Friday, June 26, 2015 at 5.00 pm at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.
The agenda and draft resolutions have been published in the BALO legal gazette on May 20, 2015 (www.journal-officiel.gouv.fr ). The BALO notice can be reviewed on the website of the company (www.pharmagest.com, Investor Relations).
15 days prior to the meeting a convening notice to attend the meeting will be published in the BALO and in a legal gazette.
Pursuant to article R225-73-1 of the French commercial code, PHARMAGEST INTERACTIVE will publish the documents prescribed by this article on its website 21 days prior to the meeting.
The shareholders may obtain any further information by request to PHARMAGEST INTERACTIVE's headquarter located in VILLERS-LES-NANCY (54600).
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in information technology for pharmacies, with a 43.5% market share, 9,800 clients and more than 800 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12% market share in Belgium and Luxembourg through its SABCO subsidiary.
As a privileged partner to pharmacists for more than 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high-potential E-Business E-Media activity intended for laboratories.
The PHARMAGEST Group is also developing innovative new solutions for Retirement Homes (Care Comes and day centres for the elderly) through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, boosts sales, optimizes purchases and improves patient advice. It is also the first permanent-impact medium for pharmacies that provides laboratories with a direct means of communication with the pharmacist and his or her patients.
Operating at the heart of the digital revolution that is gradually establishing itself in the daily life of healthcare professionals and patients alike, at the beginning of 2012 the PHARMAGEST Group created an e-Health business, bringing together subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (DO-Pill SecuR(TM) intelligent pill dispenser) and KAPELSE (electronic health devices).
Listed on Euronext Paris(TM) - Compartment B
Indices: ENTERNEXT TECH 40, CAC ® SMALL and CAC ® All-Tradable by inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN : FR 0000077687 - Reuters : PHA.PA - Bloomberg : - PMGI FP
PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance SMEs (PEA-PME)
Find out the latest news from the group at www.pharmagest.com
CONTACTS
Analyst Investor Relations:
Chief Financial Officer: Jean-Yves SAMSON
Telephone: +33(0)3 83 15 90 67 - jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO - Isabelle Aprile
Telephone: +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
